What is Inocor primarily used to treat?

Inocor, known generically as amrinone, is primarily used in the treatment of congestive heart failure. It is classified as a phosphodiesterase inhibitor that helps to increase cardiac contractility and reduce systemic vascular resistance. This is particularly beneficial for patients suffering from heart failure, as it improves hemodynamic parameters and alleviates symptoms associated with this condition. By enhancing the heart's ability to pump blood effectively, Inocor supports better overall circulation, which is crucial for patients with congestive heart failure.

While other conditions listed, such as hypertension, arrhythmias, and pneumonia, are important medical issues, Inocor is not standardly used for their management. Hypertension is typically managed with different classes of medications like ACE inhibitors or diuretics, and arrhythmias are treated with antiarrhythmic agents. Pneumonia is addressed with antibiotics rather than a medication like Inocor, which focuses on cardiac contractility and fluid management in heart failure patients.